Safety And Long-Term Immunogenicity Of The 13-Valent Pneumococcal Conjugate Vaccine In Children Who Are Solid Organ Transplant Recipients.
Phase of Trial: Phase II
Latest Information Update: 10 Feb 2012
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 10 Feb 2012 New trial record
- 09 Feb 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.